BioBag Zenzo A/S Financials, key figures and credit report
Gross profit 3 775.7 kDKK FY 2025 -40% vs 2024
EBIT 242.7 kDKK FY 2025 -91.3% vs 2024
Net debt - 581.6 kDKK FY 2025 -290.6% vs 2024
Quick ratio 1.5 FY 2025 -0.4 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 3 815.29 | 4 471.52 | 5 601.59 | 6 289.73 | 3 775.69 |
| Employee benefit expenses | -3 312.50 | -3 373.69 | -3 346.66 | -3 492.52 | -3 532.95 |
| EBIT | 502.79 | 1 097.82 | 2 254.93 | 2 797.21 | 242.74 |
| Other financial income | 48.08 | 36.72 | 0.38 | ||
| Other financial expenses | -36.51 | -55.09 | -55.94 | -52.80 | - 236.76 |
| Pre-tax profit | 466.28 | 1 042.73 | 2 247.07 | 2 781.13 | 6.37 |
| Income taxes | - 103.77 | - 231.64 | - 494.34 | - 647.94 | -2.74 |
| Net earnings | 362.51 | 811.09 | 1 752.73 | 2 133.19 | 3.63 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | 95.32 | 97.23 | 101.12 | 104.72 | 104.72 |
| Long term receivables total | |||||
| Finished products/goods | 191.09 | 138.71 | 187.07 | 283.51 | 507.48 |
| Inventories total | 191.09 | 138.71 | 187.07 | 283.51 | 507.48 |
| Current trade debtors | 3 891.87 | 5 236.84 | 8 381.47 | 3 399.86 | 2 852.20 |
| Current amounts owed by group member comp. | 19.84 | 4 230.73 | 8 571.69 | 4 810.85 | |
| Prepayments and accrued income | 57.02 | 8.12 | 80.32 | 38.36 | |
| Current other receivables | 59.33 | 1.38 | 130.59 | ||
| Current deferred tax assets | 154.00 | 154.00 | 140.94 | 300.20 | |
| Short term receivables total | 4 008.22 | 5 410.68 | 12 774.32 | 12 194.18 | 8 132.20 |
| Cash and bank deposits | 5 849.03 | 2 490.86 | 757.93 | 240.74 | 773.59 |
| Cash and cash equivalents | 5 849.03 | 2 490.86 | 757.93 | 240.74 | 773.59 |
| Balance sheet total (assets) | 10 143.66 | 8 137.48 | 13 820.45 | 12 823.16 | 9 517.99 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 400.00 | 400.00 | 400.00 | 400.00 | 400.00 |
| Shares repurchased | 1 500.00 | 2 300.00 | |||
| Retained earnings | 1 771.35 | 2 133.86 | 1 444.95 | 897.67 | 3 030.87 |
| Profit of the financial year | 362.51 | 811.09 | 1 752.73 | 2 133.19 | 3.63 |
| Shareholders equity total | 2 533.86 | 3 344.95 | 5 097.67 | 5 730.87 | 3 434.50 |
| Provisions | 565.00 | 1 100.00 | 1 100.00 | 640.63 | 118.80 |
| Non-current liabilities total | |||||
| Advances received | 621.95 | 192.50 | |||
| Current trade creditors | 645.40 | 815.32 | 2 243.97 | 1 334.31 | 1 161.89 |
| Current owed to group member | 297.07 | 133.48 | 1 429.79 | 545.92 | 192.03 |
| Other non-interest bearing current liabilities | 5 480.39 | 2 743.73 | 3 756.51 | 4 571.44 | 4 610.77 |
| Current liabilities total | 7 044.80 | 3 692.53 | 7 622.77 | 6 451.67 | 5 964.69 |
| Balance sheet total (liabilities) | 10 143.66 | 8 137.48 | 13 820.45 | 12 823.16 | 9 517.99 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated